Great Point Partners’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Great Point Partners’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-15,300	Closed	-$604K	–	49
2018 Q1	$604K	Buy	+15,300	New	+$595K	0.09%	34

Great Point Partners's ARNA Position: Q1 2022 in Review

Great Point Partners sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 530,670 shares — an estimated $49.3M sold.

Great Point Partners first reported a position in ARNA in Q2 2017 and held it in 13 quarters. The position peaked at $82M in Q2 2020. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

Great Point Partners reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
Great Point Partners sold 530,670 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $49.3M.
Great Point Partners first reported a position in Arena Pharmaceuticals Inc in Q2 2017 and held it in 13 quarters.
Great Point Partners's Arena Pharmaceuticals Inc position peaked at $82M in Q2 2020.
1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Great Point Partners's 13F filing for Q1 2022, filed 16 May 2022.